معرفی
Han-I Wang is a Research Fellow in Health Economics at the York Trial Unit (YTU), University of York, specializing in economic evaluation, health outcomes research, and the integration of machine learning techniques in health economic analysis. She completed her Doctorate in health economics at the University of York in 2011 and previously worked in the Epidemiology Cancer Statistics Group (2011-2019) and the Mental Health and Addiction Research Group (2019-2023) before joining YTU in 2023.
Education:
- PhD in Health Economics, University of York
- MSc in Computer Science with Artificial Intelligence, University of York
- MSc in Health Economics (with distinction), Taipei Medical University
Dr. Wang's research spans multiple domains including cancer, mental health, tobacco use, chronic diseases like diabetes, and the health impacts of climate change. She has particular expertise in distributional cost-effectiveness analysis to assess both efficiency and equity impacts of health interventions, and increasingly incorporates machine learning and deep learning techniques for clinical outcome prediction, cancer risk stratification, and healthcare needs forecasting. Her work often involves large, complex patient-level datasets and advanced simulation techniques, including both cohort and individual-level models.
Her research portfolio demonstrates a clear trajectory toward integrating advanced computational methods with traditional health economics, with recent publications focusing on autism interventions, long COVID epidemiology, and hematological malignancies. The work shows increasing sophistication in methodology, moving from basic economic evaluations to complex modeling incorporating machine learning and big data analytics.
Scientific Recognition:
- ISPOR Annual European Congress poster award (2023)
- ISPOR Annual European Congress poster award (2018)
- ISPOR Annual European Congress poster award (2015)
- Member of editorial board for Pharmacoeconomics journal (2021-present)
Dr. Wang actively collaborates with academic teams and government organizations across the UK and internationally. She has contributed to numerous significant research projects including the SCIMITAR SA programme addressing tobacco-related conditions in severe mental illness, BioDriveAFS investigating antifungal stewardship in acute leukemia, and studies on sustainable healthcare in Trinidad and Tobago. She serves as a reviewer for NIHR grants and has delivered invited talks at international conferences across Europe, Asia, and the Americas.
Her work demonstrates a commitment to translating health economic research into practical applications that can inform healthcare policy and improve patient outcomes, with particular attention to equity considerations in healthcare delivery.
